SG172498A1 - Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors - Google Patents
Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors Download PDFInfo
- Publication number
- SG172498A1 SG172498A1 SG2009085804A SG2009085804A SG172498A1 SG 172498 A1 SG172498 A1 SG 172498A1 SG 2009085804 A SG2009085804 A SG 2009085804A SG 2009085804 A SG2009085804 A SG 2009085804A SG 172498 A1 SG172498 A1 SG 172498A1
- Authority
- SG
- Singapore
- Prior art keywords
- platinum
- electrode
- psa
- nanoparticle
- immunosensor
- Prior art date
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title claims abstract description 119
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 41
- 230000001404 mediated effect Effects 0.000 title claims abstract description 15
- 229910052697 platinum Inorganic materials 0.000 title claims abstract description 13
- 239000003054 catalyst Substances 0.000 title claims abstract description 12
- 230000008021 deposition Effects 0.000 title abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 14
- 239000001257 hydrogen Substances 0.000 claims abstract description 14
- 230000003321 amplification Effects 0.000 claims abstract description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 9
- 230000035945 sensitivity Effects 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 230000006911 nucleation Effects 0.000 claims abstract description 7
- 238000010899 nucleation Methods 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 7
- 239000000523 sample Substances 0.000 claims description 5
- 239000003792 electrolyte Substances 0.000 claims description 2
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 30
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 30
- 238000001514 detection method Methods 0.000 description 26
- 239000000243 solution Substances 0.000 description 23
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000010931 gold Substances 0.000 description 18
- 230000009467 reduction Effects 0.000 description 15
- 239000002245 particle Substances 0.000 description 14
- 229920000962 poly(amidoamine) Polymers 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 10
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 235000019253 formic acid Nutrition 0.000 description 10
- 150000001412 amines Chemical class 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 8
- 238000001075 voltammogram Methods 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 7
- 229920000053 polysorbate 80 Polymers 0.000 description 7
- 229910021607 Silver chloride Inorganic materials 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 6
- -1 Ag* Chemical class 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000003929 acidic solution Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 229940127121 immunoconjugate Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- LSHROXHEILXKHM-UHFFFAOYSA-N n'-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCN LSHROXHEILXKHM-UHFFFAOYSA-N 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000003917 TEM image Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 238000002484 cyclic voltammetry Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000000835 electrochemical detection Methods 0.000 description 3
- 238000002848 electrochemical method Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- LDTLDBDUBGAEDT-UHFFFAOYSA-N methyl 3-sulfanylpropanoate Chemical compound COC(=O)CCS LDTLDBDUBGAEDT-UHFFFAOYSA-N 0.000 description 3
- 239000002159 nanocrystal Substances 0.000 description 3
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 150000003141 primary amines Chemical group 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003950 stripping voltammetry Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000004627 transmission electron microscopy Methods 0.000 description 2
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- ULGGZAVAARQJCS-UHFFFAOYSA-N 11-sulfanylundecan-1-ol Chemical compound OCCCCCCCCCCCS ULGGZAVAARQJCS-UHFFFAOYSA-N 0.000 description 1
- INOAASCWQMFJQA-UHFFFAOYSA-N 16-sulfanylhexadecanoic acid Chemical compound OC(=O)CCCCCCCCCCCCCCCS INOAASCWQMFJQA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229910019029 PtCl4 Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940008201 allegra Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000011903 deuterated solvents Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- FBEIPJNQGITEBL-UHFFFAOYSA-J tetrachloroplatinum Chemical compound Cl[Pt](Cl)(Cl)Cl FBEIPJNQGITEBL-UHFFFAOYSA-J 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000004832 voltammetry Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
- G01N27/3278—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction involving nanosized elements, e.g. nanogaps or nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Catalysts (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
PLATINUM NANOPARTICLE LABEL MEDIATED DEPOSITION OF PLATINUMA method for providing an ultrasensitive electrochemical immunosensor,comprising using a platinum (Pt) enhancement process to grow Pt catalyst basedon the principle of seed-mediated nucleation and growth; using target-selectiveprobe molecule-conjugated Pt nanoparticle labels as seeds wherein the resultingPt catalyst accelerates a hydrogen evolution reaction in a proton-rich electrolytemedium for signal amplification, thereby improving the sensitivity of theelectrochemical immunosensor or biosensor.FIGURE 1
Description
PLATINUM NANOPARTICLE LABEL MEDIATED DEPOSITION OF PLATINUM
CATALYST FOR ULTRASENSITIVE ELECTROCHEMICAL IMMUNOSENSORS
The invention relates to a method for detecting biomolecules, such as DNA and protein tumor markers, in a sample, and in particular, to an electrochemical method therefor. The method is suitable for use in diagnostic kits for DNA and protein tumor markers.
The following discussion of the background to the invention is intended to facilitate an understanding of the present invention. However, it should be appreciated that the discussion is not an acknowledgment or admission that any of the material referred to was published, known or part of the common general knowledge in any jurisdiction as at the priority date of the application.
There is an increasing need for the development of simple, rapid and ultrasensitive immunobiosensors for the detection of proteins. These sensors would be immensely beneficial for applications such as early stage disease diagnosis, detection of biological threats, and drug screening. The advantage of using an immunosensor over other types of sensors in these applications lies in their high selectivity, which originates from the high selectivity and binding affinity of the antibody to its antigen. Consequently, the need for analyte enrichment and purification may be bypassed. However, since the antibody—antigen binding only causes minimal physiochemical changes, this binding event cannot be detected by most analytical instruments. Typical detection methods employ antibodies that are conjugated with a substance that can be read out easily by spectrophotometric, piezoelectric or electrochemical methods. Nanoparticles have been widely used for this purpose.
In the field of ultrasensitive electrochemical immunosensors, nanoparticles can be used to increase the loading of electrochemically detectable species so as to enhance the sensitivity of the sensor. Both metallic nanoparticles and semiconductor quantum dots have been employed. In most cases, after the labeling step, a strong oxidant would be used to dissolve the nanoparticles to produce a solution containing a large quantity of ions (e.g. Ag*, Cd** and Cu®*), and then stripping voltammetry or ion selective electrode would be used to detect the dissolved ions. To avoid this complicated pre-oxidation step, it has been developed an electrochemical magnetic immunosensor based on magnetic beads and gold nanoparticle labels. The captured gold nanoparticle labels on the immunosensor surface were directly quantified by electrochemical stripping analysis. Poly(guanine)-functionalized silica nanoparticles have been used as biological labels for the sensitive electrochemical immunoassay. After a complete sandwich immunoassay, the concentration of the target analyte-dependent guanine was detected electrochemically using electrogenerated Ru(bpy)*** as an electron transfer mediator. To advance biosensor sensitivity, nanoparticle labels have also been used as seeds to catalyze the precipitation of Au or Ag to further increase the loading of Au or Ag. Previously, it has been reported an electrochemical immunoassay based on silver growth upon colloidal gold labels.
After silver metal dissolution in acid, stripping voltammetry was used for detection.
It has further been reported an amplified electrochemical immunoassay for the quantitative detection of rabbit immunoglobulin G analyte based on square-wave stripping voltammetric detection of Au from the mediated deposition of Au nanoparticle labels after Au was dissolved in HBr/Br; solution. Recently, an ultrasensitive electrochemical immunosensor for PSA has also been reported. The detection antibody was conjugated with Ag nanoparticle labels, which allowed the implementation of a silver enhancement approach based on a seeded-mediated nucleation and growth mechanism. Following that, a unique solid-state Ag/AgCl process facilitated detection by significantly amplifying the signal.
It is desirable to provide an alternative ultrasensitive electrochemical method for detecting DNA and other biomolecules (such as protein markers).
Throughout this document, unless otherwise indicated to the contrary, the terms “comprising”, “consisting of”, and the like, are to be construed as non-exhaustive, or in other words, as meaning “including, but not limited to”.
Herein it is described a novel signal amplification strategy for the development of ultrasensitive electrochemical immunosensors. The amplification strategy is based on platinum catalyzing the hydrogen evolution reaction. To demonstrate its advantage, the electrochemical signal enhancement strategy has been applied as a novel prostate-specific antigen (PSA) immunosensor. The immunosensing protocol utilized a gold electrode with the PSA capture antibodies bound to its surface via covalent bonding. After PSA was bound to the electrode surface, a secondary platinum nanoparticle-labeled detection antibody was used to complete the sandwich immunosensor. The resulting electrode was then dipped in a platinum developer solution containing 1 mM of PtCls*, 0.1 M of formic acid (reductant) and 0.5% Tween 80 (pH 6.5) to generate bare platinum catalysts in close proximity to the Au electrode surface through a seed-mediated nucleation and growth mechanism. The signal readout was obtained electrochemically via a
Pt-catalyzed hydrogen evolution reaction in an acidic aqueous medium containing 10 mM of HCI and 1 M of KCI. A detection limit of 1 fg/ml was achieved.
In the figures, which illustrate, by way of example only, embodiments of the present invention,
FIG. 1 shows a schematic of the electrochemical PSA biosensor based on Pt- catalyzed hydrogen evolution for signal amplification.
FIG. 2 shows TEM images of Pt nanoparticles synthesized with (a) 0.25 g/100 ml and (b,c) 0.10 g/100 ml of capping agents. (d) Pt nanoparticle cluster—antibody conjugates. Scale bars in these images are 5 nm, 0.5 um, 10 nm and 0.2 um, respectively.
FIG. 3 shows cyclic voltammograms of proton redox process obtained in an acidic solution containing 10 mM of HCI and 1 M of KCI with different electrodes (2 mm diameter): (—) bare Au electrode, (—) Au electrode modified with a mixed thiol monolayer (10% MUOH, 90% MHA), (—) bare Pt electrode, and (0) our PSA immunosensor, when the PSA analyte concentration is 10 nM.
FIG. 4 shows (a) effect of Pt enhancement time (from the top curve to the bottom curve: 0, 2, 5, 10, 15, 30, 45 and 60 min) on the voltammetric response of
PSA immunosensors in an aqueous solution containing 10 mM of HCl and 1 M of
KCI. (b) Dependence of the steady-state diffusion controlled limiting current and peak current (data obtained from (a)) on the enhancement time for (=) 0.1 pg/ml and (OJ) 0 pg/ml of PSA.
FIG. 5 shows calibration curves of the PSA immunosensor obtained with a Pt enhancement time of (A) 10 min and (00) 30 min.
FIG. 6 shows formation of disulfide-based polyamidoamines (mixed oligomers) 2.
Detection of biomolecules such as DNA and protein tumor markers is important in diagnostic tests for cancer and other diseases. The purpose of this invention is to detect low concentrations of these biomolecules by incorporating significant signal amplification. Specifically, this invention utilizes a unique Pt enhancement process to grow Pt catalyst based on the principle of seed-mediated nucleation and growth, using target-selective probe molecule-conjugated Pt nanoparticle labels as seeds. The resulting Pt catalyst accelerates the hydrogen evolution reaction in a proton-rich electrolyte medium for signal amplification, improving the sensitivity of electrochemical biosensors. As Pt can effectively catalyze hydrogen evolution in an acidic solution, considerable signal amplification can be achieved.
The basic principle of the sensing strategy involves several key steps: (1) immobilization of spacer molecules and target-selective probe molecules on the electrode surface, (2) assembly of target analytes on the modified electrode, (3) labeling of the target analytes with Pt nanoparticles conjugated with target- selective probe molecules, (4) Pt enhancement based on seed-mediated nucleation and growth in a unique Pt developer solution consisting of 1 mM of
PtCls%, 0.1 M of formic acid (reductant) and 0.5% of Tween 80 (pH 6.5), (5) electrochemical detection of Pt-catalyzed hydrogen evolution reaction in an acidic solution containing 10 mM of HCl and 1 M of KCI. The signal obtained is related to the concentration of the biomolecules, allowing for proper quantification of the biomolecules. The Pt enhancement step and the Pt-catalyzed hydrogen evolution step represent the key innovation for this biosensor, leading to a detection limit that is amongst the lowest reported thus far.
Herein it is reported an ultrasensitive electrochemical detection strategy using
Pt-catalyzed hydrogen evolution for signal amplification in the sensing of PSA illustrated in FIGURE 1. In this case, analyte PSA was captured by the capture antibodies covalently bound on the electrode surface. Subsequently, the captured antigens were sandwiched with a Pt nanoparticle-labeled PSA detection antibody.
The resulting electrode was then dipped into a platinum developer solution containing 1 mM of PtCl,*, 0.1 M of formic acid and 0.5% of Tween 80 (pH 6.5). Pt nanoparticle labels catalyzed the reduction of PtCl4* by formic acid to form Pt particles on the electrode surface. This Pt-modified electrode was then placed into an acidic solution for proton reduction using a voltammetric method. The current measured depended on the coverage of Pt catalyst on the electrode surface, which could be correlated to the PSA concentration.
The advantages of using Pt nanoparticle-catalyzed H* reduction include: (1) the
H* reduction is electrochemically reversible on Pt surface, and (2) the Pt surface is much more active than other conductive surfaces, e.g. carbon, ITO, Au or Ag.
Thus, the interference from the proton reduction at the uncovered electrode surface is minimal. Consequently, a clean background can be expected during voltammetric experiments when non-Pt electrodes are used. Additional advantages include: (3) the diffusion coefficient for protons is approximately 1x10 cm?S™", which is at least an order magnitude higher than any other species, and (4) inorganic acids are normally stable and highly soluble in water. Pt nanoparticle labels have been used as catalysts for the electrochemical reduction of HO; in amplified electrochemical detection of DNA by others previously. However, using
Pt nanoparticle labels in protein detection is more challenging. The electrode and the Pt nanoparticle labels conjugated to the detection antibody are separated by the antibodies, which are typically 10 nm in diameter. The electron tunneling through such a long distance is too slow to be detected. Therefore, a Pt enhancement step by seed-mediated nucleation and growth is required to introduce a Pt catalyst in close proximity to the electrode surface. Seed-mediated
Pt deposition has been attained using a Pt developer solution consisting of Pt salt and ascorbic acid. However, it normally takes a few hours for Pt to grow with this developer solution. Thus, it is not suitable for application to rapid protein detection.
Experimental
Materials and reagents
PSA from human serum (P-3338) was purchased from Sigma-Aldrich.
Monoclonal antibodies to PSA were obtained from Meridian Life Science Inc.
Biodesign International (M86433M as capture antibody and M86111M as detection antibody). O,0’-bis[2-(N-succinimidyl-succinylamino)ethyl] polyethylene glycol 3,000 (NHS-PEG-NHS), N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC), N-succinimidyl ester (NHS), 16-mercapto-1-hexadecanoic acid (16-MHA), 11- mercapto-1-undecanol (11-MUOH), ethylamine, NaBH4, HoPtClg, KoPtCly, formic acid, Tween 80, NaOH, boric acid, sodium tetraborate, Tris hydroxymethyl (aminomethane) (TRIS), Na;HPO,, NaH,PO4, KCI and HCI were obtained from
Sigma-Aldrich. Nanopure water (resistivity > 18 KQ cm) was used in the studies.
Apparatus
Cyclic voltammetry was performed with a CHI 760C electrochemical workstation (CH Instruments, Texas). A conventional 3-electrode system was employed. A 2 mm-diameter gold electrode (CH Instruments), a platinum wire and an Ag/AgCl (3M KCI) electrode (CH Instruments) were employed as the working electrode, counter electrode, and reference electrode, respectively. TEM experiments were performed on a JEOL JEM-3010 electron microscope (200 kV). Centrifugation was conducted with an Allegra 64R Centrifuge (Beckman Coulter, California).
Synthesis of Pt nanoparticles and Pt nanoparticle-antibody conjugates 1 mM of H,PtCls and 2.5 mg/ml of disulfide-based polyamidoamines were dissolved in 200 ml of nanopure water, and stirred for 10 min. Disulfide-based polyamidoamines contained both thiol groups for strong Pt nanoparticle stabilization, and primary amine groups for further bioconjugation (see the following paragraphs below). The solution turned brown upon the addition of 48 mg of NaBH, dissolved in 2 ml water, suggesting the formation of Pt nanoparticles.
The Pt nanoparticles were then concentrated to 10 ml via water evaporation. 30 ml of acetone were added to the solution to precipitate the Pt nanoparticles via centrifugation. The precipitate was collected and re-dissolved in 10 ml of nanopure water. This procedure was repeated twice to obtain pure Pt nanoparticles. TEM image shown in FIGURE 2a showed that the size of the Pt nanocrystals was approximately 3 nm. However, sedimentation of these Pt nanocrystals in a pure aqueous solution via centrifugation was impossible even at 21,000 rpm. For ease of centrifugation and separation of the Pt nanoparticle-antibody conjugates from the excess antibodies after conjugation, less capping reagent (1 mg/ml) was used while keeping the amount of the other reagents unchanged. The resulting Pt nanoparticles were purified using the same protocol as described above. Low- resolution transmission electron microscopy (TEM) showed that the Pt particles have a diameter of 40 nm as shown in FIGURE 2b. However, high-resolution TEM image shown in FIGURE 2c illustrated that these particles were aggregates of 3- nm Pt nanocrystals.
The Pt nanoparticle clusters were conjugated with detection antibodies using
NHS-PEG-NHS linker, which reacted with the primary amines from both Pt nanoparticles and detection antibodies. Pt nanoparticle clusters (2.5 mg) were diluted in 1 ml of borate buffer (pH 7.5), and mixed with an excess amount of NHS-
PEG-NHS 3000 (10 mg dissolved in 100 ul of dimethyl sulfoxide (DMSO)). After 15 min of incubation, the NHS-PEG-NHS-conjugated nanoparticles were sedimented by centrifugation at 13,000 rpm to remove excess NHS-PEG-NHS.
The recovered activated particles were immediately dissolved in 1 ml of borate buffer (pH 7.5) containing 0.1 mg of M86111M detection antibodies, and incubated for 2 h under shaking. 100 ul of TRIS buffer (1 M, pH 7.4) were added to block any free NHS groups. The final Pt nanoparticle—antibody conjugates were separated by centrifugation at 13,000 rpm to remove excess detection antibodies. TEM image indicated that the Pt nanoparticles were stable upon conjugation (see
FIGURE 2d). The conjugated nanoparticles were kept at 4°C.
Preparation of sandwich immunosensor
Au electrode of 2 mm-diameter for the immunosensor was first polished carefully using 0.3-um alumina slurry, and electrochemically cleansed in a H,SO4 solution (0.5 M) by cycling the potential between -0.2 V and 0.8 V vs. a Pt wire quasi-reference electrode for 5 min. The electrode was then washed with nanopure water, and dipped into 100 ul of an ethanolic solution containing 0.1 mM of 16-MHA and 0.9 mM of 11-MUOH overnight. 11-MUOH was used as a spacer to obtain an optimal density of the COOH groups on the electrode surface and to prevent non-specific adsorption. The electrode was then soaked for 2 h in 100 pl of phosphate buffered saline (PBS) (0.05 M, pH 7.5) containing 5 mM of NHS, 20 mM of EDC and 100 ug/ml of M86433M capture antibodies. The antibodies were covalently bound to the electrode through the conjugation of amine groups from the antibodies with the activated carboxyl groups on the electrode surface. Next, 10 pl of ethanolamine solution (1 M) were added to block any free activated carboxyl groups. The resulting antibody-modified electrode was washed with nanopure water, and then with 10 mM of glycine (pH 2.2) to remove any non- covalently bound antibodies. The electrode prepared was exposed to PSA analyte concentrations of 0—10 ng/ml for 30 min. It was washed with PBS before dipping into the Pt nanoparticle-labeled detection antibodies. After 15 min, the electrode was thoroughly washed with 0.01 M of TRIS buffer (pH 7.4) containing 0.15 M of
NaCl to remove non-specifically bound Pt nanoparticle-labeled detection antibodies. The electrode was then carefully washed with nanopure water. It was next dipped into the Pt developer solution containing 1 mM of PtCl,%, 0.1 M of formic acid and 0.5% of Tween 80 (pH 6.5) for a certain amount of time. The electrode was washed again with nanopure water before conducting cyclic voltammetric measurements in an aqueous solution containing 01 M of KCI and 0.01 M of HCI.
Results and Discussion
Formulation of the Pt developer solution
An important step in this immunosensing strategy was the rapid seed-mediated generation and deposition of bare Pt particles on the electrode surface in the aqueous phase at room temperature under physiological pH using a Pt developer solution. We found that a Pt developer solution containing 1 mM of PtCls* and 0.1
M of formic acid reductant was stable for approximately 30 min, and that the Pt nanoparticle seeds could efficiently catalyze the reduction of PtCl,> by formic acid to produce Pt. To increase the stability of the Pt developer solution from approximately 30 min to more than 1 day without significantly decreasing the rate of seed-mediated deposition of Pt, 0.5% of Tween 80 was added to the developer solution. The pH of the developer solution was adjusted to 6.5 to avoid the detachment of PSA or detection antibody from the electrode surface in an acidic environment (due to the presence of 0.1 M of formic acid in the Pt enhancement step).
FIGURE 3 shows the cyclic voltammograms of proton redox processes obtained at different electrodes in an acidic solution containing 10 mM of HCI and 1 M of KCI. Since the reduction of H" occurred at a potential close to that of O reduction, 10 mM of HCI was used so that the signal due to O, reduction was negligible compared to that of H" reduction. Consequently, removal of O, was not required during the experiments. The results showed that the bare Pt electrode was much more active for facilitating the hydrogen evolution process. A well- defined voltammogram was obtained with a formal potential of -0.417 V vs.
Ag/AgCl (taken as the average of the anodic peak potential, -0.384 V vs. Ag/AgCl, and the cathodic peak potential, -0.449 V vs. Ag/AgCl). In contrast, proton reduction at the bare Au electrode surface was much slower with a very large overpotential. The peak potential of -0.741 V vs. Ag/AgCl for proton reduction at a bare Au electrode was almost 0.3 V more negative than that at the Pt electrode.
The overpotential of proton reduction was even higher at the Au electrode modified with a mixed thiol monolayer. In contrast, the voltammogram obtained using the PSA immunosensor when the analyte PSA concentration was 10 nM, was essentially identical to that obtained at a bare Pt electrode. This suggested that the Pt particles generated with the developer solution have good activity for proton reduction.
Effect of Pt enhancement time
The amount of Pt deposited onto the electrode surface during the Pt enhancement step, and hence the electrochemical response of the immunosensor was time-dependent. Experiments were therefore conducted to investigate the effect of the Pt enhancement time on the voltammetric response of the PSA immunosensor. The transition from a steady-state sigmoidal-shaped voltammogram to a transient peak-shaped voltammogram is clearly illustrated in
FIGURE 4a, as expected. When the enhancement time was short enough (2-5 min) and the Pt particle density and/or size was sufficiently small, (i.e. the distance between the particles was 10 times their diameter), every individual Pt particle behaved like an independent microelectrode. Subsequently, the mass transport was governed by radial diffusion, and sigmoidally shaped steady-state voltammograms were observed. When the enhancement time was longer than 1 h, the electrode surface would be almost entirely covered with Pt particles. The mass transport to the electrode was then governed by planar diffusion. The voltammogram obtained after Pt enhancement treatment resembled that obtained at a Pt disc electrode (see FIGURE 3). When the enhancement time increased from 10 min to 45 min, the Pt particle density and/or size increased, causing the diffusion layer of each Pt particle microelectrode to overlap. Therefore, the transition of steady-state voltammogram to an ideal transient voltammogram of a macro-disc electrode was observed. Controlled experiments conducted in the absence of PSA showed that background currents were small. This suggested that thiol-modified Au electrodes were almost inert towards the catalytic growth of Pt, and that the non-specific adsorption of PSA or detection antibody was minimal.
Values of the steady-state diffusion-controlled limiting currents or peak currents obtained from FIGURE 4a are summarized in FIGURE 4b.
Calibration curves
The results in FIGURE 4 implied that a higher sensitivity would be expected if a longer Pt enhancement time was applied. However, longer enhancement time might also decrease the dynamic concentration response range of the immunosensor. To examine this, two calibration curves were obtained using different Pt enhancement times (FIGURE 5). In both cases, the PSA immunosensors have a good response to PSA over a wide concentration range.
When a Pt enhancement time of 10 min was used, the steady-state diffusion limiting current or peak current increased when the PSA concentration increased from 10 fg/ml to 10 pg/ml. The peak current approached a plateau when the PSA concentration was higher than 0.1 ng/ml. The results also showed that the sensitivity of the PSA immunosensor increased and its dynamic response range shifted towards a lower concentration range (1 fg/ml to 1 pg/ml) when a longer Pt enhancement time of 30 min was used.
Synthesis and characterization of disulfide-based polyamidoamines 1. Materials and methods 1.1. Materials
Methyl-3-mercaptopropionate, tris(2-aminoethyl)amine (96%), pentaethylene- hexamine, dimethylsulfoxide (DMSO) and tetrahydrofuran (THF) were all purchased from Sigma-Aldrich and used as received. 1.2. Methods "H and "*C NMR spectra. Spectra were recorded on a Bruker AVANCE 400 at 400 MHz and 100 MHz, respectively, using the deuterated solvent indicated. CS
ChemNMR Pro version 6.0 (Upstream Solutions GbmH Scientific Software
Engineering CH-6052 Hergiswil, Switzerland) was employed to analyze the spectra.
Gel permeation chromatography (GPC). The molecular weight (M,,) of polyamidoamine was analyzed by GPC (Waters 2690, MA, USA) with a differential refractometer detector (Waters 410, MA, USA). The mobile phase consisted of 0.5
M of sodium acetate and 0.5 M of acetic acid solution with a flow rate of 1 mL/min.
A Shodex OHpak SB-803 HQ (8.0 mm x 300 mm) column was used. Number and weight average molecular weights (M, and M,,) as well as polydispersity indices were calculated from a calibration curve using a series of dextran standards (Aldrich, Missouri, USA) with molecular weights ranging from 667 to 778000.
Elemental analysis. The nitrogen content of the polyamidoamine was determined by elemental analysis using Perkin-Elmer Instruments Analyzer 2400
CHN/CHNS and Eurovector EA3000 Elemental Analyzers. 2. Synthesis and characterization of disulfide-based polyamidoamines (mixed oligomers)
2.1 Formation of amine monomer (1) 10 ml of tris(2-aminoethyl)amine (0.067 mol), 60 ml of methanol and 17 ml of epichlorohydrin (0.22 mol) were placed in a flask under nitrogen. The mixture was left to stir in an ice bath for 24 h. Next, 250 ml of pentaethylenehexamine (1.08 mol) were added to the contents of the flask in conjunction with 100 ml of DMSO.
The mixture was left to stir at 90°C for 24 h. The contents of the flask were then dialyzed against flowing water using dialysis tubing with a molecular weight cut-off of 500 Da (Spectrum Laboratories, USA) for 1 day, followed by freeze drying. &1(400 MHz, D0) 3.70 (1H, m, -CH,-CH(OH)CHa-); 3.10-2.20 (m, -NH-CH,-CH.,-
NH-, -CH,-CH(OH)CH2-, and -NH-CH2-CH2-N(-CH2-CH2-NH-),). 8¢(100 MHz, D,0) 67, 58, 56, 55, 53, 52, 49, 48, 47, 45, 44, 39, 38 and 37. 2.2 Formation of disulfide-based polyamidoamines (mixed oligomers) (2) 6.5 g of the amine monomer (1) (0.0081 mol) were added to a flask with 150 ml of methanol and 0.70 ml of methyl-3-mercaptopropionate (0.0064 mol). The mixture was then left to stir at 60°C for 24 h. The excess methanol was removed under vacuum, and then the mixture was precipitated in THF and dried using a vacuum oven. 8y(400 MHz, D,0) 3.70 (1H, m, -CH»-CH(OH)CH_-); 3.30-3.20 (2H, t, -NH-CH,-CH,-NH-C(=0)-CH,-CH,-S-); 3.10-2.20 (m, -NH-CH,-CH>-NH-, -NH-
CH3-CH,-NH-C(=0)-CH,-CH,-S-S-, CH2-CH2-NH-C(=0)-CH»-CH»>-SH, -CH>-
CH(OH)CH--, and -NH-CH,-CH,-N(-CH2-CH2-NH-),). 8¢(100 MHz, D,0O) 165, 67, 58, 56, 55, 53, 52, 49, 48, 47, 45, 44, 39, 38, 37, 27 and 21. 3. Results and discussion 3.1. Synthesis and characterization of disulfide-based polyamidoamines (mixed oligomers)
The oligomeric polyamidoamine was prepared via a two-step procedure. The first step involved a ring-opening mechanism in conjunction with nucleophilic substitution. For this simple procedure, pentaethylenehexamine was employed as the main amine as shown in FIGURE 6. Briefly, we initially formed the amine monomer (1) compound by reacting the core amine, tris(2-aminoethylene)amine with epichlorohydrin in methanol via ring opening in an ice bath for 24 h. This was followed by reacting the core with excess pentaethylenehexamine via nucleophilic substitution in an oil bath at 90°C for 24 h. Subsequently, the amine monomer (1) compound was purified via dialysis in water. We then reacted the purified amine monomer (1) with the thiol ester, methyl-3-mercaptopropionate, via nucleophilic substitution at 60°C for 24 h in methanol. Lastly, the excess methanol was removed under vacuum, and the disulfide-based polyamidoamines (mixed oligomers) were obtained as a crude mixture via precipitation in THF. The oligomeric mixture was then dried in a vacuum oven.
The chemical structure of both the amine monomer (1) and the disulfide-based polyamidoamines (mixed oligomers) (2) were confirmed using 'H and 3C NMR spectroscopy. In addition, with the aid of GPC analysis, the weight average molecular weight of the disulfide-based polyamidoamines (mixed oligomers) was determined to be 2.8 kDa with a polydispersity index of 1.4.
Following from the above description, it has been demonstrated that a new Pt developer solution containing 1 mM of PtCl%, 0.1 M of formic acid and 0.5% of
Tween 80 (pH 6.5) was very effective for the seed-mediated growth of Pt particles.
The Pt particles generated using this method were active towards electrochemical hydrogen evolution. The advantage of using this Pt enhancement strategy and the
Pt-catalyzed hydrogen evolution for the development of ultrasensitive immunosensors has been successfully demonstrated in the example of PSA detection. A detection limit of 1 fg/ml has been achieved. Further advantages include: (i) simplicity, as the approach does not require complex and expensive optical systems; and (ii) high sensitivity, associated with the high catalytic activity of Pt towards the hydrogen evolution reaction as compared to other metals, high solubility and high diffusion coefficient of proton in water.
Besides providing for amplified biomolecules detection and diagnostic kits for
DNA and protein tumor markers, the above description is also suitable for the fabrication of Pt-modified surface for catalytic reactions (e.g. fuel cell applications).
Although the foregoing invention has been described in some detail by way of illustration and example, and with regard to one or more embodiments, for the purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes, variations and modifications may be made thereto without departing from the spirit or scope of the invention as described in the appended claims.
Claims (1)
1. A method for providing an ultrasensitive electrochemical immunosensor, comprising: — using a platinum (Pt) enhancement process to grow Pt catalyst based on the principle of seed-mediated nucleation and growth; — using target-selective probe molecule-conjugated Pt nanoparticle labels as seeds; wherein the resulting Pt catalyst accelerates a hydrogen evolution reaction in a proton-rich electrolyte medium for signal amplification, thereby improving the sensitivity of the electrochemical immunosensor or biosensor.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2009085804A SG172498A1 (en) | 2009-12-23 | 2009-12-23 | Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors |
PCT/SG2010/000482 WO2011078800A1 (en) | 2009-12-23 | 2010-12-22 | Method for the detection of an analyte |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2009085804A SG172498A1 (en) | 2009-12-23 | 2009-12-23 | Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors |
Publications (1)
Publication Number | Publication Date |
---|---|
SG172498A1 true SG172498A1 (en) | 2011-07-28 |
Family
ID=44196052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2009085804A SG172498A1 (en) | 2009-12-23 | 2009-12-23 | Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors |
Country Status (2)
Country | Link |
---|---|
SG (1) | SG172498A1 (en) |
WO (1) | WO2011078800A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102608188A (en) * | 2012-03-30 | 2012-07-25 | 山东理工大学 | Preparation method of current mode immunosensor used for detecting pesticide residue |
EP2990033A1 (en) * | 2014-08-26 | 2016-03-02 | Carlina Technologies | Process of nanoprecipitation of proteins and peptides with low molecular weight |
CN105699464B (en) * | 2016-03-05 | 2018-04-13 | 济南大学 | A kind of preparation method and application of the immunosensor based on cuprous oxide doping Pd nano particle mark |
CN107907557B (en) * | 2017-11-21 | 2020-04-28 | 苏州大学 | WS (WS)2Verification method for Pt deposition selection by S atoms in nanosheets |
CN110006987B (en) * | 2019-05-06 | 2021-09-21 | 甘肃有色冶金职业技术学院 | Method for continuously detecting gold, palladium, platinum, rhodium, iridium and ruthenium in alloy |
CN112129820B (en) * | 2020-10-12 | 2021-08-03 | 江南大学 | Construction method and application of specific electrochemical sensor for HER2 detection |
-
2009
- 2009-12-23 SG SG2009085804A patent/SG172498A1/en unknown
-
2010
- 2010-12-22 WO PCT/SG2010/000482 patent/WO2011078800A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011078800A1 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ganganboina et al. | Graphene quantum dots decorated gold-polyaniline nanowire for impedimetric detection of carcinoembryonic antigen | |
Qin et al. | A novel carbon quantum dots signal amplification strategy coupled with sandwich electrochemiluminescence immunosensor for the detection of CA15-3 in human serum | |
Zhang et al. | Pt nanoparticle label-mediated deposition of Pt catalyst for ultrasensitive electrochemical immunosensors | |
Ahmad et al. | An electrochemical sandwich immunosensor for the detection of HER2 using antibody-conjugated PbS quantum dot as a label | |
Çevik et al. | Construction of novel electrochemical immunosensor for detection of prostate specific antigen using ferrocene-PAMAM dendrimers | |
Lai et al. | Dual signal amplification of glucose oxidase-functionalized nanocomposites as a trace label for ultrasensitive simultaneous multiplexed electrochemical detection of tumor markers | |
Dong et al. | Electrogenerated chemiluminescence resonance energy transfer between luminol and CdSe@ ZnS quantum dots and its sensing application in the determination of thrombin | |
He et al. | A sensitive amperometric immunosensor for carcinoembryonic antigen detection with porous nanogold film and nano-Au/chitosan composite as immobilization matrix | |
Jeong et al. | Increased electrocatalyzed performance through dendrimer-encapsulated gold nanoparticles and carbon nanotube-assisted multiple bienzymatic labels: highly sensitive electrochemical immunosensor for protein detection | |
An et al. | Sensitive electrochemical immunosensor for α-synuclein based on dual signal amplification using PAMAM dendrimer-encapsulated Au and enhanced gold nanoparticle labels | |
Ma et al. | Electrochemical immunosensors for sensitive detection of neuron-specific enolase based on small-size trimetallic Au@ Pd^ Pt nanocubes functionalized on ultrathin MnO2 nanosheets as signal labels | |
Lin et al. | Nanogold/mesoporous carbon foam-mediated silver enhancement for graphene-enhanced electrochemical immunosensing of carcinoembryonic antigen | |
Zhao et al. | A sensitive electrochemical aptasensor for Mucin 1 detection based on catalytic hairpin assembly coupled with PtPdNPs peroxidase-like activity | |
Qiao et al. | Enhancing the electrochemiluminescence of luminol by chemically modifying the reaction microenvironment | |
Campuzano et al. | Nanozymes in electrochemical affinity biosensing | |
Zhang et al. | Ultrasensitive electrochemical microcystin-LR immunosensor using gold nanoparticle functional polypyrrole microsphere catalyzed silver deposition for signal amplification | |
WO2009032901A1 (en) | Biosensors and related methods | |
Qi et al. | Functionalization of single-walled carbon nanotubes with protein by click chemistry as sensing platform for sensitized electrochemical immunoassay | |
Wang et al. | Ultrasensitive detection of carcinoembryonic antigen by a simple label-free immunosensor | |
Zhang et al. | Nanogold-functionalized magnetic beads with redox activity for sensitive electrochemical immunoassay of thyroid-stimulating hormone | |
Higashi et al. | Chemically regulated ROS generation from gold nanoparticles for enzyme-free electrochemiluminescent immunosensing | |
SG172498A1 (en) | Platinum nanoparticle label mediated deposition of platinum catalyst for ultrasensitive electrochemical immunosensors | |
US20100059391A1 (en) | Method for detecting biomolecules and use thereof | |
Liu et al. | A novel aptamer-mediated CuInS 2 quantum dots@ graphene oxide nanocomposites-based fluorescence “turn off–on” nanosensor for highly sensitive and selective detection of kanamycin | |
Shahdost-fard et al. | An impedimetric aptasensor based on water soluble cadmium telluride (CdTe) quantum dots (QDs) for detection of ibuprofen |